Details
Category: Volume 07 Issue 03 March 2019
Hits: 1142

Title: Comparison of Dosimetric Parameters in CT and MRI based planning in Image Guided Cervical Cancer Brachytherapy- Prospective Single Institutional Study

Authors: Saravanan.S, Vijayasree T.N.

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.81

Abstract

Purpose: To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy – prospective single institutional study.

Materials & Methods: A total of 79 histologically proven cervical cancer patients of Stage IIB to IIIB, completed concurrent Chemoradiation were enrolled in a prospective Institutional Board approved brachytherapy protocol between March 2017 and May 2018. All of them underwent brachytherapy using a MRI-compatible tandom and ovoids applicator. Planning is done using both CT and MRI for the first fraction. The tumour and organs at risk (bladder, rectum and sigmoid) were contoured separately on CT and on MRI using clinical findings combined with GEC-ESTRO guidelines. The Dose Volume (DVH) parameters of Tumor and OARs were analysed using paired t test. P values < 0.05 were considered significant.

As per our Departmental protocol, all patients received 7Gy x 3fractions.

Results: The mean V100 is higher for CT based planning compared to MRI and D90 is higher for MRI based planning with statistically significant difference (p -). D2cc of bladder, rectum is same in both. D2cc for sigmoid is higher in MRI based planning.

Conclusion: Both CT and MRI based planning can be done. MRI gives better tissue delineation hence of HRCTV, resulting in lesser V100 and higher D90, so dose to actual tumor can be escalated in bulky disease with respect bladder and rectum.

Keywords: Carcinoma cervix, Brachytherapy, Computed tomography, Magnetic resonance imaging, Dosimetric Parameters.

References

  1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Freddie Bray BSc, MSc, PhD Jacques Ferlay ME ,Isabelle Soerjomataram MD, MSc, PhD ,Rebecca L. Siegel MPH ,Lindsey A. Torre MSPH , Ahmedin Jemal PhD, DVM First published: 12 September 2018,
  2. Lanciano RM, Martz K, Coia LR, Hanks GE. Tumour and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat. Oncol Biol Phys 1991;20:95–100.
  3. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999;43:359–66.
  4. Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45. 
  5. Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol.  2006;78(1):67–77.
  6. Brodman M, Friedman F, Jr, Dottino P, Janus C, Plaxe S, Cohen C. A comparative study of computerized tomography, magnetic resonance imaging, and clinical staging for the detection of early cervix cancer. GynecolOncol. 1990;36 (3):409–12. [PubMed].
  7. Mayr NA, Tali ET, Yuh WT, Brown BP, Wen BC, Buller RE, et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 1993;189 (2):601–8. [PubMed].
  8. Kirisits C, Potter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J RadiatOncolBiol Phys. 2005;62(3):901–11. 
  9. Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, Pedersen EM, van Limbergen E, Haie-Meder C, Pötter R. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012 Apr;103(1):113-22. doi: 10.1016/j.radonc. 2011.12.024. Epub 2012 Jan 30.
  10. Pötter R, Georg P, Dimopoulos JCA, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiotherapy and Oncology. 2011;100 (1):116–23. 
  11. Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. ActaOncol. 2013;52 (7):1510–9. 
  12. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Potter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J RadiatOncolBiol Phys. 2007; 68 (2):491–8.
  13. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, 3rd, et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2014; 90(2):320–8.
  14. Wang F1, Tang Q1, Lv G2, Zhao F1, Jiang X1, Zhu X1, Li X1, Yan S Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy: A systematic review. Brachytherapy.2017 Mar - Apr;16 (2):353-365.
  15. Swanick CW, Castle KO, Vedam S, et al. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J RadiatOncolBiol Phys. 2016;96(4):793-800.
  16. Vick CW, Walsh JW, Wheelock JB, Brewer WH. CT of the normal and abnormal parametria in cervical cancer. AJR Am J Roentgenol. 1984;143(3):597–603. 
  17. Rahul KrishnatryFiruza D. Patel Paramjeet Singh Suresh C. Sharma Arun S. Oinam  Arvind K. Shukla, CT or MRI for Image-based Brachytherapy in Cervical Cancer. Japanese Journal of Clinical Oncology, Volume 42, Issue 4, 1 April 2012, Pages 309-313
  18. Eskander RN, Scanderbeg D, Saenz CC, Brown M, Yashar C. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring. Int J Gynecol Cancer 2010;20:47–53.
  19. Zolciak-Siwinska A, Kowalczyk A, Sikorska K, Bijok M, Michalski W, Gruszczynska E. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy. Brachytherapy. 2018 Jul - Aug;17(4):667-672.

Corresponding Author

Vijayasree T N

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.